A 3D View: Improving Acute and Preventive Treatment of Migraine in the Primary Care Setting Using Novel Agents

FACULTY

Anne H. Calhoun, MD, FAHS
Partner/Co-Founder, Carolina Headache Institute
Professor, Department of Anesthesiology
Professor, Department of Psychiatry
University of North Carolina
Chapel Hill, NC

Andrew Charles, MD
Professor of Neurology
Director, UCLA Goldberg Migraine Program
Meyer and Renee Luskin Chair in Migraine and Headache Studies
David Geffen School of Medicine at
University of California
Los Angeles, CA

PROGRAM OVERVIEW

This case-based enduring activity will cover the treatment and management of patients with migraines.

TARGET AUDIENCE

This educational activity is intended for primary care providers and doctors of osteopathy working with patients with migraine headaches.

LEARNING OBJECTIVES

On completing the program, attendees should be able to:

• Review best practices for diagnosing migraine headaches including the process of differential diagnosis
• Assess efficacy and safety profiles of investigational agents for the acute treatment of migraine, as well as calcitonin-gene related peptide (CGRP)-targeting agents for the prevention of episodic and chronic migraine
• Describe burdens associated with migraine headaches and the use of patient reported outcomes for measuring the impact of new and established migraine therapies
• Discuss strategies for managing migraine that include the integration of novel treatment options and the application of methods for overcoming patient- and physician-dependent barriers in clinical practice

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to
provide continuing medical education for physicians.
This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this online activity for a maximum of 1.5 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the online activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in treating and managing patients with
migraine. CNE Credits: 1.5 ANCC Contact Hours

CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

AOA Credit: The AOA Bureau of OMED is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. The AOA Bureau of OMED, as a co- sponsor with Med Learning Group, designates this enduring program for a maximum of 1.5 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participant in this enduring activity.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Anne Calhoun, MD, is a consultant for Amgen, Depomed, Lilly, and Teva and is on the speakers bureau for Amgen, Avanir, Depomed, Lilly, Merck, Pernix, and Teva. She previously conducted research for Allergan, Autonomic Technologies, ElectroCore, Scion Neurostim, and Avanir.

Andrew Charles, MD, is a consultant for Alder, Amgen, Biohaven, Eli Lilly, and eNeura. He has conducted research for Takeda Pharmaceuticals.

CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE CONTENT REVIEW
The content of this activity was peer-reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

The staff, planners and managers reported the following financial relationships or relationships to
products or devices they or their spouse/life partner have with commercial interests related to the
content of this CME/CNE activity:

Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development of Med Learning Group has nothing to disclose.
Ana Maria Albino, Program Manager of Med Learning Group has nothing to disclose.
Chris Drury, Scientific and Medical Services of Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP of Accreditation and Outcomes of Med Learning Group has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, faculty may mention the use of medications for both FDA-approved and non- approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures.
2. Participate in the online activity.
3. Submit the evaluation form to Med Learning Group.

Participants will receive their certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement
information at http://medlearninggroup.com/privacy‐policy/

RELEASE DATE: February 5, 2019

EXPIRATION DATE: February 5, 2020

View Activity